EYESOL
Live / Registered — Cancelled — Section 71 (as of 16 Jan 2026)
What this means for you
Registered since 02 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79237959
- Registration number
- 5790514
- Mark type
- Design + words
- Filed
- 13 Mar 2018
- Published for opposition
- 16 Apr 2019
- Registered
- 02 Jul 2019
- Attorney of record
- Pina M Campagna
Goods and services
- Class 005 — Pharmaceuticals: Liquid and semisolid pharmaceutical preparations for ophthalmic use, for the treatment of ophthalmic diseases, namely, diseases of the anterior and posterior segment of the eye
Owner
- Novaliq GmbH, DE
- Novaliq GmbH, DE
- Novaliq GmbH, DE
Prosecution history
- 16 Sept 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 16 Jan 2026 — CANCELLED SECTION 71
- 02 Jul 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Nov 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Oct 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Oct 2019 — FINAL DISPOSITION PROCESSED
- 02 Oct 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2019 — PUBLISHED FOR OPPOSITION
- 27 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE